Literature DB >> 18613997

Importance of low-grade albuminuria.

John Danziger1.   

Abstract

The well-described association between chronic kidney disease and cardiovascular disease is typically thought to originate from loss of renal function, as estimated by the glomerular filtration rate. However, recent data suggest that urinary albumin excretion has an important role in this association. Albuminuria is a marker of underlying vascular dysfunction and has been correlated with structural and functional integrity of the vasculature. Although the traditional upper limit of normal daily albumin excretion has been 30 mg/d, recent epidemiologic data suggest that levels in the general population are actually much lower. Further, within this range of low-grade albuminuria (LGA), increasing excretion rates are associated with increasing risk of cardiovascular disease. This association is independent of renal function, and in the earliest stages of chronic kidney disease, LGA seems to be a more important determinant than the glomerular filtration rate. This emerging association underscores the complexity of albumin excretion, in which subtle changes in albumin excretion reflect widespread vascular processes. Using the key words albuminuria, low-grade albuminuria, and microalbuminuria in a PubMed search of literature from January 1, 1995, to February 29, 2008, this review summarizes the most recent data on LGA and its association with cardiovascular and renal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18613997     DOI: 10.4065/83.7.806

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  25 in total

1.  Association between urinary IgG and relative risk for factors affecting proteinuria in type 2 diabetic patients.

Authors:  Sandesh Mohan; Kiran Kalia; Jyoti Mannari
Journal:  Indian J Clin Biochem       Date:  2012-06-24

2.  Dietary phthalates and low-grade albuminuria in US children and adolescents.

Authors:  Leonardo Trasande; Sheela Sathyanarayana; Howard Trachtman
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

3.  Albuminuria and the risk of incident stroke and stroke types in older adults.

Authors:  M I Aguilar; E S O'Meara; S Seliger; W T Longstreth; R G Hart; P E Pergola; M G Shlipak; R Katz; M J Sarnak; D E Rifkin
Journal:  Neurology       Date:  2010-09-01       Impact factor: 9.910

4.  Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.

Authors:  Mauro Gori; Michele Senni; Deepak K Gupta; David M Charytan; Elisabeth Kraigher-Krainer; Burkert Pieske; Brian Claggett; Amil M Shah; Angela B S Santos; Michael R Zile; Adriaan A Voors; John J V McMurray; Milton Packer; Toni Bransford; Martin Lefkowitz; Scott D Solomon
Journal:  Eur Heart J       Date:  2014-06-30       Impact factor: 29.983

5.  High-normal albuminuria and risk of heart failure in the community.

Authors:  Saul Blecker; Kunihiro Matsushita; Anna Köttgen; Laura R Loehr; Alain G Bertoni; L Ebony Boulware; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2011-05-06       Impact factor: 8.860

6.  Effect of Shen-qi-di-huang decoction on reducing proteinuria by preserving nephrin in adriamycin-induced nephropathy rats.

Authors:  Hongyu Chen; Qin Zhu; Xuanli Tang; Man Min; Leqin Jie; Lijing Chen
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-06-01

7.  Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure?

Authors:  S Morteza Farasat; Carolina Valdes; Veena Shetty; Denis C Muller; Josephine M Egan; E Jeffrey Metter; Luigi Ferrucci; Samer S Najjar
Journal:  Hypertension       Date:  2009-12-14       Impact factor: 10.190

Review 8.  Identification and management of albuminuria in the primary care setting.

Authors:  Louis Kuritzky; Robert Toto; Peter Van Buren
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-01       Impact factor: 3.738

9.  Urine albumin excretion, within normal range, reflects increasing prevalence of metabolic syndrome in patients with essential hypertension.

Authors:  Gregory Vyssoulis; Eva Karpanou; Pangiotis Spanos; Stella-Maria Kyvelou; Dionysios Adamopoulos; Christodoulos Stefanadis
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08       Impact factor: 3.738

Review 10.  Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead.

Authors:  Rigas Kalaitzidis; George Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.